Functions of the ectodomain and cytoplasmic tyrosine phosphatase domains of receptor protein tyrosine phosphatase Dlar in vivo

被引:26
|
作者
Krueger, NX
Reddy, RS
Johnson, K
Bateman, J
Kaufmann, N
Scalice, D
Van Vactor, D
Saito, H
机构
[1] Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan
[2] Harvard Univ, Sch Med, Dana Farber Canc Inst, Ctr Canc, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA
[5] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA
[6] Harvard Univ, Sch Med, Ctr Canc, Boston, MA 02115 USA
关键词
D O I
10.1128/MCB.23.19.6909-6921.2003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The receptor protein tyrosine phosphatase (PTPase) Dlar has an ectodomain consisting of three immunoglobulin (Ig)-like domains and nine fibronectin type III (FnIII) repeats and a cytoplasmic domain consisting of two PTPase domains, membrane-proximal PTP-D1 and C-terminal PTP-D2. A series of mutant Dlar transgenes were introduced into the Drosophila genome via P-element transformation and were then assayed for their capacity to rescue phenotypes caused by homozygous loss-of-function genotypes. The Ig-like domains, but not the FnIII domains, are essential for survival. Conversely, the FnIII domains, but not the Ig-like domains, are required during oogenesis, suggesting that different domains of the Mar ectodomain are involved in distinct functions during Drosophila development. All detectable PTPase activity maps to PTP-D1 in vitro. The catalytically inactive mutants of Dlar were able to rescue Dlar(-/-) lethality nearly as efficiently as wild-type Dlar transgenes, while this ability was impaired in the PTP-D2 deletion mutants DlarDeltaPTP-D2 and Dlar(bypass). DlarC1929S, in which PTP-D2 has been inactivated, increases the frequency of bypass phenotype observed in Dlar(-/-)genotypes, but only if PTP-D1 is catalytically active in the transgene. These results indicate multiple roles for PTP-D2, perhaps by acting as a docking domain for downstream elements and as a regulator of PTP-D1.
引用
收藏
页码:6909 / 6921
页数:13
相关论文
共 50 条
  • [41] Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatase-1B
    Haj, FG
    Markova, B
    Klaman, LD
    Bohmer, FD
    Neel, BG
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (02) : 739 - 744
  • [42] MURINE PROTEIN-TYROSINE PHOSPHATASE-PEST, A STABLE CYTOSOLIC PROTEIN-TYROSINE-PHOSPHATASE
    CHAREST, A
    WAGNER, J
    SHEN, SH
    TREMBLAY, ML
    BIOCHEMICAL JOURNAL, 1995, 308 : 425 - 432
  • [43] Rat protein tyrosine phosphatase η physically interacts with the PDZ domains of syntenin
    Iuliano, R
    Trapasso, F
    Samà, I
    Le Pera, I
    Martelli, ML
    Lembo, F
    Santoro, M
    Viglietto, G
    Chiariotti, L
    Fusco, A
    FEBS LETTERS, 2001, 500 (1-2) : 41 - 44
  • [44] PROTEIN TYROSINE PHOSPHATASE DOMAINS FROM THE PROTOCHORDATE STYELA-PLICATA
    MATTHEWS, RJ
    FLORES, E
    THOMAS, ML
    IMMUNOGENETICS, 1991, 33 (01) : 33 - 41
  • [45] The Protein Tyrosine Phosphatase Receptor Delta Regulates Developmental Neurogenesis
    Tomita, Hideaki
    Cornejo, Francisca
    Aranda-Pino, Begona
    Woodard, Cameron L.
    Rioseco, Constanza C.
    Neel, Benjamin G.
    Alvarez, Alejandra R.
    Kaplan, David R.
    Miller, Freda D.
    Cancino, Gonzalo I.
    CELL REPORTS, 2020, 30 (01): : 215 - +
  • [46] Heparan sulfate proteoglycans are ligands for receptor protein tyrosine phosphatase σ
    Aricescu, AR
    McKinnell, IW
    Halfter, W
    Stoker, AW
    MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (06) : 1881 - 1892
  • [47] No obvious abnormality in mice deficient in receptor protein tyrosine phosphatase β
    Harroch, S
    Palmeri, M
    Rosenbluth, J
    Custer, A
    Okigaki, M
    Shrager, P
    Blum, M
    Buxbaum, JD
    Schlessinger, J
    MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (20) : 7706 - 7715
  • [48] Expression of a receptor protein tyrosine phosphatase in human glial tumors
    Norman, SA
    Golfinos, JG
    Scheck, AC
    JOURNAL OF NEURO-ONCOLOGY, 1998, 36 (03) : 209 - 217
  • [49] Receptor protein tyrosine phosphatase ζ as a therapeutic target for glioblastoma therapy
    Müller, S
    Lamszus, K
    Nikolich, K
    Westphal, M
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2004, 8 (03) : 211 - 220
  • [50] Regulation of insulin receptor signaling by the protein tyrosine phosphatase TCPTP
    Galic, S
    Klingler-Hoffmann, M
    Fodero-Tavoletti, MT
    Puryer, MA
    Meng, TC
    Tonks, NK
    Tiganis, T
    MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (06) : 2096 - 2108